Joseph Zeleznik is Technical Director, North America for IMCD US Pharma, having responsibility for conducting training and customer seminars, as well as advising with formulation development. Mr. Zeleznik collaborates to develop prototype formulations, demonstrating IMCD’s ingredient benefits. He works with IMCD’s principals to promote product awareness. Mr. Zeleznik currently serves as IPEC-Americas Chair-elect. Mr. Zeleznik was Manager, Technical and Regulatory Affairs at MEGGLE USA, having oversight for MEGGLE’s North American operations. Mr. Zeleznik was Associate Director, R&D with JRS PHARMA and Research Manager with Penwest Pharmaceuticals. Mr. Zeleznik has 30 years’ industry experience, specializing in developing HFEs and other novel excipients.